Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-07-02T06:26:25.418Z Has data issue: false hasContentIssue false

Chapter 37 - Termination of Pregnancy

Medical Methods

from Section 2B - Sexual and Reproductive Healthcare: Termination of Pregnancy

Published online by Cambridge University Press:  16 January 2024

Johannes Bitzer
Affiliation:
University Women's Hospital, Basel
Tahir A. Mahmood
Affiliation:
Victoria Hospital, Kirkcaldy
Get access

Summary

Medical abortion is the use of medications, rather than surgical means to induce an abortion. The World Health Organization (WHO) recommends the use of a combination of mifepristone (a progesterone-receptor antagonist) followed by misoprostol (a synthetic prostaglandin) [1].

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

World Health Organization. Medical management of abortion. Geneva: World Health Organization, 2018.Google Scholar
Baird, DT, Rodger, M, Cameron, IT, Roberts, I. Prostaglandins and antigestagens for the interruption of early pregnancy. J Reprod Fertil Suppl. 1988;36:173–9. www.ncbi.nlm.nih.gov/pubmed/3193407.Google ScholarPubMed
Akin, A, Dabash, R, Dilbaz, B et al. Increasing women’s choices in medical abortion: A study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone. European Journal of Contraception and Reproductive Health Care: Official Journal of the European Society of Contraception. 2009;14(3):169–75. https://bit.ly/3Y4dRHh.CrossRefGoogle ScholarPubMed
Kapp, N, Eckersberger, E, Lavelanet, A, Rodriguez, MI. Medical abortion in the late first trimester: A systematic review. Contraception. 2019;99(2):7786. www.ncbi.nlm.nih.gov/pubmed/30444970.CrossRefGoogle ScholarPubMed
Raymond, EG, Shannon, C, Weaver, MA, Winikoff, B. First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review. Contraception. 2013;87(1):2637. www.sciencedirect.com/science/article/pii/S0010782412006439.CrossRefGoogle ScholarPubMed
National Institute for Health and Care Excellence. Abortion care. NG140 edition. London: National Institute for Health and Care Excellence, 2019. www.nice.org.uk/guidance/NG140.Google Scholar
Cameron, ST, Glasier, A, Dewart, H, Johnstone, A, Burnside, A. Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: A service evaluation. Contraception. 2012;86(1):6773. https://bit.ly/3HVuH5w.CrossRefGoogle ScholarPubMed
Reeves, MF, Fox, MC, Lohr, PA, Creinin, MD. Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention. Ultrasound in Obstetrics and Gynecology. 2009;34(1):104–9. https://doi.org/10.1002/uog.6404.CrossRefGoogle Scholar
Ngoc, NTN, Shochet, T, Raghavan, S et al. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: A randomized controlled trial. Obstetrics and Gynecology. 2011;118(3):601–8. https://bit.ly/3jvGIW8.CrossRefGoogle ScholarPubMed
Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion: Evidence-based clinical guideline number 7. London: Royal College of Obstetricians and Gynaecologists, 2011. http://bit.ly/3l9NnWr.Google Scholar
Avraham, S, Gat, I, Duvdevani, N-R et al. Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: A double-blind, randomized, controlled study. Fertility and Sterility. 2012;97(3):612–15. https://bit.ly/3HTInhC.CrossRefGoogle ScholarPubMed
Livshits, A, Machtinger, R, David, LB et al. Ibuprofen and paracetamol for pain relief during medical abortion: A double-blind randomized controlled study. Fertility and Sterility. 2009;91(5):1877–80. https://bit.ly/3wWhSla.CrossRefGoogle ScholarPubMed
Fiala, C, Swahn, ML, Stephansson, O, Gemzell-Danielsson, K. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13–22 weeks gestation. Hum Reprod. 2005;20(11):3072–7. www.ncbi.nlm.nih.gov/pubmed/16055455.CrossRefGoogle ScholarPubMed
Jackson, E, Kapp, N. Pain control in first-trimester and second-trimester medical termination of pregnancy: A systematic review. Contraception. 2011;83(2):116–26. https://bit.ly/3wUEnHe.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×